We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Stagwell
STGW
$2.21B
| $1.03M | ﹤0.01% |
394,695
+143,534
| +57% | +$409K |
|
1502
Interactive Brokers
IBKR
$41B
| $1.02M | ﹤0.01% |
74,920
-154,844
| -67% | -$2.07M |
|
|
PTLA
1503
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.02M | ﹤0.01% |
52,403
| – | – |
|
1504
Simpson Manufacturing
SSD
$7.99B
| $1.02M | ﹤0.01% |
18,803
-16,473
| -47% | -$967K |
|
1505
OraSure Technologies
OSUR
$273M
| $1.02M | ﹤0.01% |
86,951
-25,921
| -23% | -$345K |
|
1506
Outfront Media
OUT
$5.46B
| $1.02M | ﹤0.01% |
56,976
+11,467
| +25% | +$218K |
|
|
HA
1507
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.02M | ﹤0.01% |
38,471
+8,429
| +28% | +$285K |
|
|
PDCE
1508
DELISTED
PDC Energy, Inc.
PDCE
| $1.02M | ﹤0.01% |
34,142
-44,812
| -57% | -$1.8M |
|
1509
QuidelOrtho
QDEL
$849M
| $1.01M | ﹤0.01% |
20,776
-1,221
| -6% | -$72.9K |
|
|
KANG
1510
DELISTED
iKang Healthcare Group, Inc.
KANG
| $1.01M | ﹤0.01% |
49,393
| – | – |
|
|
EXAS
1511
DELISTED
Exact Sciences
EXAS
| $1M | ﹤0.01% |
15,888
-11,725
| -42% | -$805K |
|
1512
XPO
XPO
$23.4B
| $1M | ﹤0.01% |
50,828
-26,369
| -34% | -$731K |
|
1513
Rayonier Advanced Materials
RYAM
$603M
| $998K | ﹤0.01% |
93,676
+50,276
| +116% | +$684K |
|
1514
Hamilton Lane
HLNE
$5.47B
| $995K | ﹤0.01% |
26,884
-8,820
| -25% | -$330K |
|
1515
Energizer
ENR
$1.5B
| $993K | ﹤0.01% |
21,986
-222,807
| -91% | -$11.8M |
|
1516
Brighthouse Financial
BHF
$3.43B
| $992K | ﹤0.01% |
32,559
+12,394
| +61% | +$484K |
|
|
CTRL
1517
DELISTED
Control4 Corporation
CTRL
| $992K | ﹤0.01% |
56,349
-25,692
| -31% | -$608K |
|
|
AXAS
1518
DELISTED
Abraxas Petroleum Corp
AXAS
| $990K | ﹤0.01% |
45,392
-57,174
| -56% | -$1.99M |
|
|
FMBI
1519
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $989K | ﹤0.01% |
49,927
-3,186
| -6% | -$73.2K |
|
1520
Central Garden & Pet Co Class A
CENTA
$2.39B
| $984K | ﹤0.01% |
39,349
-35,811
| -48% | -$857K |
|
1521
Resources Connection
RGP
$146M
| $979K | ﹤0.01% |
68,909
-46,404
| -40% | -$751K |
|
1522
Wolfspeed
WOLF
$1.58B
| $979K | ﹤0.01% |
22,884
-25,403
| -53% | -$1.03M |
|
|
NFX
1523
DELISTED
Newfield Exploration
NFX
| $979K | ﹤0.01% |
66,771
-810,616
| -92% | -$16.3M |
|
|
SAGE
1524
DELISTED
Sage Therapeutics
SAGE
| $978K | ﹤0.01% |
10,209
-605
| -6% | -$69.2K |
|
1525
Spire
SR
$4.84B
| $978K | ﹤0.01% |
+13,202
| New | +$998K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.